Search research articles
Contact Us
Filters
Showing results (11-20 of 52) with videos related to
Page
of 6
Sort By:
Lancet (London, England)
|
August 31, 2010
Extensively drug-resistant tuberculosis in South Africa
Helen Cox, Nathan Ford, Cheryl McDermid, et al.
Bulletin of the World Health Organization
|
September 24, 2005
Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa
David Coetzee, Katherine Hilderbrand, Andrew Boulle, et al.
Journal of the International AIDS Society
|
June 27, 2020
Population-wide differentials in HIV service access and outcomes in the Western Cape for men as compared to women, South Africa: 2008 to 2018: a cohort analysis
Meg Osler, Morna Cornell, Nathan Ford, et al.
AIDS (London, England)
|
August 24, 2004
Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa
David Coetzee, Andrew Boulle, Katherine Hildebrand, et al.
Journal of the International AIDS Society
|
May 1, 2014
A three-tier framework for monitoring antiretroviral therapy in high HIV burden settings
Meg Osler, Katherine Hilderbrand, Claudine Hennessey, et al.
JAMA
|
February 20, 2002
Do patents prevent access to drugs for HIV in developing countries?
Eric Goemaere, Anne-Valerie Kaninda, Laura Ciaffi, et al.
Bulletin of the World Health Organization
|
July 15, 2015
The need to accelerate access to new drugs for multidrug-resistant tuberculosis
Helen S Cox, Jennifer J Furin, Carole D Mitnick, et al.
Plos One
|
February 23, 2010
Nevirapine-associated early hepatotoxicity: incidence, risk factors, and associated mortality in a primary care ART programme in South Africa
Kathryn M Chu, Andrew M Boulle, Nathan Ford, et al.
Journal of the International AIDS Society
|
July 26, 2015
Paediatric HIV treatment failure: a silent epidemic
Jonathan M Bernheimer, Gem Patten, Thembisa Makeleni, et al.
The Lancet. Infectious Diseases
|
April 2, 2011
Rational use of moxifloxacin for tuberculosis treatment
Helen Cox, Nathan Ford, Salmaan Keshavjee, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 52) with videos related to
Sort By:
Page
of 6
Lancet (London, England)
|
August 31, 2010
Extensively drug-resistant tuberculosis in South Africa
Helen Cox, Nathan Ford, Cheryl McDermid, et al.
Bulletin of the World Health Organization
|
September 24, 2005
Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa
David Coetzee, Katherine Hilderbrand, Andrew Boulle, et al.
Journal of the International AIDS Society
|
June 27, 2020
Population-wide differentials in HIV service access and outcomes in the Western Cape for men as compared to women, South Africa: 2008 to 2018: a cohort analysis
Meg Osler, Morna Cornell, Nathan Ford, et al.
AIDS (London, England)
|
August 24, 2004
Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa
David Coetzee, Andrew Boulle, Katherine Hildebrand, et al.
Journal of the International AIDS Society
|
May 1, 2014
A three-tier framework for monitoring antiretroviral therapy in high HIV burden settings
Meg Osler, Katherine Hilderbrand, Claudine Hennessey, et al.
JAMA
|
February 20, 2002
Do patents prevent access to drugs for HIV in developing countries?
Eric Goemaere, Anne-Valerie Kaninda, Laura Ciaffi, et al.
Bulletin of the World Health Organization
|
July 15, 2015
The need to accelerate access to new drugs for multidrug-resistant tuberculosis
Helen S Cox, Jennifer J Furin, Carole D Mitnick, et al.
Plos One
|
February 23, 2010
Nevirapine-associated early hepatotoxicity: incidence, risk factors, and associated mortality in a primary care ART programme in South Africa
Kathryn M Chu, Andrew M Boulle, Nathan Ford, et al.
Journal of the International AIDS Society
|
July 26, 2015
Paediatric HIV treatment failure: a silent epidemic
Jonathan M Bernheimer, Gem Patten, Thembisa Makeleni, et al.
The Lancet. Infectious Diseases
|
April 2, 2011
Rational use of moxifloxacin for tuberculosis treatment
Helen Cox, Nathan Ford, Salmaan Keshavjee, et al.
Page
of 6